296 related articles for article (PubMed ID: 26107264)
1. Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.
Sei JJ; Haskett S; Kaminsky LW; Lin E; Truckenmiller ME; Bellone CJ; Buller RM; Norbury CC
PLoS Pathog; 2015 Jun; 11(6):e1004941. PubMed ID: 26107264
[TBL] [Abstract][Full Text] [Related]
2. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.
Tewalt EF; Grant JM; Granger EL; Palmer DC; Heuss ND; Gregerson DS; Restifo NP; Norbury CC
PLoS Pathog; 2009 May; 5(5):e1000457. PubMed ID: 19478869
[TBL] [Abstract][Full Text] [Related]
3. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
5. Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo.
Tewalt EF; Maynard JC; Walters JJ; Schell AM; Berwin BL; Nicchitta CV; Norbury CC
Immunology; 2008 Dec; 125(4):480-91. PubMed ID: 18489571
[TBL] [Abstract][Full Text] [Related]
6. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
7. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection.
Wakim LM; Bevan MJ
Nature; 2011 Mar; 471(7340):629-32. PubMed ID: 21455179
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
[TBL] [Abstract][Full Text] [Related]
9. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting cross-presentation of tumor antigen in human DC.
Faure F; Mantegazza A; Sadaka C; Sedlik C; Jotereau F; Amigorena S
Eur J Immunol; 2009 Feb; 39(2):380-90. PubMed ID: 19130478
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
Mitchell DA; Nair SK; Gilboa E
Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
[TBL] [Abstract][Full Text] [Related]
12. Effective Priming of Herpes Simplex Virus-Specific CD8
Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
[TBL] [Abstract][Full Text] [Related]
13. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
15. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
Wolf BJ; Princiotta MF
Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
17. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.
Probst HC; van den Broek M
J Immunol; 2005 Apr; 174(7):3920-4. PubMed ID: 15778347
[TBL] [Abstract][Full Text] [Related]
18. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
Segura E; Villadangos JA
Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Nov; 177(9):6018-24. PubMed ID: 17056526
[TBL] [Abstract][Full Text] [Related]
20. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
